THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in advanced ovarian cancer and other solid tumours. Suitable for ...
XPENG will launch in the UK in early 2025 with the introduction of the advanced G6 mid-size SUV, offering British consumers high-performance, sustainable mobility International Motors Ltd (IML) ...
AUCKLAND, New Zealand, Nov. 19, 2024 /PRNewswire/ -- UnionPay International ("UPI" or "the Company") announced, marking a milestone in New Zealand's public transport sector. All Auckland Transport (AT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback